Literature DB >> 30027571

Reactivity and Selectivity of Iminium Organocatalysis Improved by a Protein Host.

Alexander R Nödling1, Katarzyna Świderek2, Raquel Castillo2, Jonathan W Hall1, Antonio Angelastro1, Louis C Morrill1, Yi Jin1, Yu-Hsuan Tsai1, Vicent Moliner2, Louis Y P Luk1.   

Abstract

There has been growing interest in performing organocatalysis within a supramolecular system as a means of controlling reaction reactivity and stereoselectivity. Here, a protein is used as a host for iminium catalysis. A pyrrolidine moiety is covalently linked to biotin and introduced to the protein host streptavidin for organocatalytic activity. Whereas in traditional systems stereoselectivity is largely controlled by the substituents added to the organocatalyst, enantiomeric enrichment by the reported supramolecular system is completely controlled by the host. Also, the yield of the model reaction increases over 10-fold when streptavidin is included. A 1.1 Å crystal structure of the protein-catalyst complex and molecular simulations of a key intermediate reveal the chiral scaffold surrounding the organocatalytic reaction site. This work illustrates that proteins can be an excellent supramolecular host for driving stereoselective secondary amine organocatalysis.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  enzyme models; molecular dynamics; organocatalysis; proteins; supramolecular chemistry

Mesh:

Substances:

Year:  2018        PMID: 30027571      PMCID: PMC6531919          DOI: 10.1002/anie.201806850

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


Designing host‐guest systems for organocatalysis has increasingly interested chemists.1 A molecular host provides a specific environment that dictates both selectivity and reactivity of the organocatalysis, thereby providing additional means for reaction control. Nature provides such examples, including proteins. These proteins present a hydrophobic and inherently chiral scaffold favorable for organocatalysis.2 Similar concepts have been tested previously. Small, metal‐free reagents including flavin,3 thiazolium ylides,4 pyridoxamine,5 or selenocysteine6 have been added to a protein covalently for oxidation, as well as C−C and C−N bond formation reactions. Recently, a novel artificial enzyme was created using π‐stacking organocatalysts whose selectivity can be improved by modifying the protein scaffold.1a, 7 In contrast, iminium formation by a secondary amine has become a major mode of substrate activation in organocatalysis,8 but a protein‐based host for this type of catalysis has not been achieved. Streptavidin (Sav) possesses a strong, noncovalent affinity to d‐biotin.9 Since Sav mostly binds to the ureido moiety of biotin, the valeric acid sidechain can be chemically modified for other applications, such as the production of artificial enzymes carrying either nonmetal1a, 7 or metal cofactors.10 Herein, we have adapted this technology and prepared Sav‐based hybrid catalysts carrying biotinylated secondary amine functionalities (Scheme 1). This work demonstrates that Sav, as a water‐soluble protein, can provide a microenvironment favorable for stereoselective secondary amine organocatalysis.
Scheme 1

Model of the biotinylated organocatalysts anchored to the surface of streptavidin (Sav; PDB 1STP).

Model of the biotinylated organocatalysts anchored to the surface of streptavidin (Sav; PDB 1STP). Several biotinylated organocatalysts were synthesized based on known catalytically active secondary amine motifs (Figure 1), including 4‐imidazolidinone (1–4), proline (5 and 6), and pyrrolidine (7 and 8) derivatives. The compounds 1–5 were prepared by copper‐catalyzed Huisgen 1,3‐dipolar cycloadditions of alkynylated biotin and azido‐functionalized precursors (5–47 % overall yield).11 The catalysts 6–8 were synthesized by direct coupling of biotin to either the Boc‐protected amino‐proline or amino‐pyrrolidine starting materials, followed by deprotection (48–63 % overall yield). The catalysts 1–3 and 5–8 were obtained as single stereoisomers, but an inseparable 1:1 mixture of cis‐ and trans‐isomers was formed for 4.
Figure 1

Biotinylated organocatalysts 1–8.

Biotinylated organocatalysts 1–8. The newly prepared biotinylated catalysts were used in the Michael addition of nitromethane to cinnamaldehyde (Table 1), a type of 1,4‐addition that is often used in pharmaceutical synthesis.12 Our previous analysis of this reaction indicates that water can hamper the reaction progress when used as a solvent, but enhances turnover rate when used as an additive.13 Hence, this sets the basis on how a protein scaffold can affect the efficiency of this organocatalytic reaction. For initial screening, each biotinylated catalyst (20 mol %) was incubated with cinnamaldehyde and five equivalents of nitromethane at 25 °C (see the Supporting Information). No activity was observed in either deionized water or in acidic buffer (pH 2.0–6.0). In contrast, at pH 7.0 and 8.0 the proline and pyrrolidine catalysts (5–8) were able to mediate the Michael addition as detected by GC‐MS, whereas such observations were absent for 1–4. At pH 9.0, however, significant background reaction was observed, rendering these reaction conditions unfavorable for developing stereoselective organocatalysis. In an acidic (amines are likely to be protonated (pK a≈8) and deprotonation of nitromethane (pK a≈10) is unfavorable, and these factors likely stall the progress of the organocatalysis.
Table 1

Catalyst screening for the reaction of nitromethane with cinnamaldehyde.[a]

EntryCatalystSolventYield[%][b] TOF[x h−1]e.r.[c] (S/R)
1NoneKPi 3
2PyrrolidineKPi 3
3ProlineKPi 3
4 Sav‐biotinKPi 3
5 1‐4 KPi 3
6 5 KPi 4
7 6 KPi 50.13
8 7 KPi 70.1850:50
9 8 KPi 60.1550:50
10 Sav‐5 KPi 60.15
11 Sav‐6 KPi 50.13
12 Sav‐7 KPi 300.7680:20
13 Sav‐8 KPi 150.3824:76
14 Sav‐7 [d] KPi 360.2880:20
15 Sav‐7 [e] KPi/C6D6 <2
16 Sav‐7 [e] KPi/CDCl3 <2
17 Sav‐7 [e] KPi/THF[f,g] 34[h]
18 Sav‐7 [e] KPi/EtOAc[f] 38[h] 92:8
19 Sav‐7 [e] KPi/DMSO<2
20 Sav‐7 [e] KPi/MeCN<2
21 Sav‐7 [e] KPi/MeOH804.491:9

[a] Reactions carried out for 42 h on a 3.3 μmol scale, using nitromethane (16.5 μmol), catalyst (1.0 mol %, additional 0.2 mol % Sav, 1.2 mol % active sites, for entries 4 and 10–14) in 500 μL of solvent. KPi=10 mm potassium phosphate buffer at pH 7.0 and 25 °C. [b] Conversion determined by 1H NMR spectroscopy for 5–8 and Sav‐5–Sav‐8. [c] Determined by chiral‐phase LC of the reduced product 11 a (Chiralpak IB, see the Supporting Information). [d] Reaction was carried out at 4 °C for 136 h. [e] Reactions were carried out for 18 h instead of 42 h, using 1:1 mixtures of buffer to organic solvent. [f] Cinnamic acid was observed as side product. [g] Unidentified side products and the 1,2‐addition product were observed in significant amounts up to 50 %. [h] Range of yield observed in multiple runs in these solvents. DMSO=dimethyl sulfoxide, THF=tetrahydrofuran.

Catalyst screening for the reaction of nitromethane with cinnamaldehyde.[a] [a] Reactions carried out for 42 h on a 3.3 μmol scale, using nitromethane (16.5 μmol), catalyst (1.0 mol %, additional 0.2 mol % Sav, 1.2 mol % active sites, for entries 4 and 10–14) in 500 μL of solvent. KPi=10 mm potassium phosphate buffer at pH 7.0 and 25 °C. [b] Conversion determined by 1H NMR spectroscopy for 5–8 and Sav‐5–Sav‐8. [c] Determined by chiral‐phase LC of the reduced product 11 a (Chiralpak IB, see the Supporting Information). [d] Reaction was carried out at 4 °C for 136 h. [e] Reactions were carried out for 18 h instead of 42 h, using 1:1 mixtures of buffer to organic solvent. [f] Cinnamic acid was observed as side product. [g] Unidentified side products and the 1,2‐addition product were observed in significant amounts up to 50 %. [h] Range of yield observed in multiple runs in these solvents. DMSO=dimethyl sulfoxide, THF=tetrahydrofuran. To see if the performance of organocatalysis can be improved by anchoring to a protein surface, the catalysts 5–8 were introduced to streptavidin (Sav). For the proline derivatives 5 and 6, the reaction yields at pH 7.0 were not affected by the addition of Sav and remain at about 5–6 % (Table 1; see the Supporting Information). In contrast, the reactivities of the pyrrolidines 7 and 8 were significantly improved when Sav was included, showing about a five‐ and twofold increase, respectively, in the reaction yields at pH 7.0 (k cat/k uncat=10 and ΔΔG ≠=5.71 kJ mol−1 for Sav‐7). No reaction enhancement was observed in control reactions with either l‐proline, pyrrolidine, or Sav‐biotin. This data highlights the synergistic effect observed by the introduction of 7 and 8 into the protein scaffold (Figure 2). While these two diastereomeric catalysts differ by one stereoconfiguration at the 3′‐position, the yield of the reaction catalyzed by Sav‐7 is slightly higher. Indeed, the reactivity of Sav‐7 is comparable to that of a water‐compatible derivative of the Jørgensen–Hayashi catalyst in that a similar reaction yield per mol % of catalyst was obtained.12c
Figure 2

GC‐MS traces of the noncatalyzed reaction and reactions catalyzed by Sav‐biotin, pyrrolidine, 7, and Sav‐7 at pH 7.0.

GC‐MS traces of the noncatalyzed reaction and reactions catalyzed by Sav‐biotin, pyrrolidine, 7, and Sav‐7 at pH 7.0. Whereas many traditional organocatalysts such as the MacMillan and Jørgensen–Hiyashi catalysts contain either bulky or hydrogen‐bonding groups adjacent to the reacting nitrogen atom for stereoselectivity control, these substituents are absent in 7 and 8. However, the transformation taking place on the surface of the inherently chiral Sav is anticipated to improve the stereoselectivity. This hypothesis is examined by chiral‐phase LC analyses of the catalytically enhanced reactions. In the absence of Sav, no enantioselectivity was observed. In the Sav‐7 reaction, the majority of the product contains an S configuration at C3, giving an enantiomeric ratio of 80:20. Conversely, the R stereoisomer was preferentially formed in the Sav‐8 reaction (Table 1, entries 12 and 13). These results clearly indicate that the binding of the catalysts to Sav causes noticeable improvement in enantioselectivity. A crystal structure at a resolution of 1.1 Å was obtained to pinpoint the interactions between the secondary amine catalyst and protein scaffold. The amide bond in the valeric moiety undergoes hydrogen bonding with Ser88, which is frequently seen when biotin is functionalized by amide‐bond formation.10f,10h,10j In previous Sav‐based artificial metalloenzymes, the location of the metal catalyst is often unclear because either the ligand is inherently flexible or the metal catalyst dissociated during crystallography.10f,10h,10j In contrast, the location of the secondary amine catalyst is clearly revealed in this work. The pyrrolidinyl moiety forms a hydrogen bond with Ser112, which has been shown to be important in artificial metalloenzyme design.10f, 10h, 10j Other residues surrounding the organocatalytic reaction are also revealed, including Leu124 and Lys121. Notably, Lys121 was also found to play critical role in the development of the Sav‐based anion‐π enzyme dictating the activity of the catalytically important tertiary amine.1a However, this residue likely plays a different role here, as it is distant from the catalytic amine atom (8.1 and ca. 7.3 Å based on the X‐ray and MD simulations, respectively). Since Lys121 is within proximity to C3 and the phenyl moiety of the intermediate (4–5 Å), it likely dictates how the nucleophile approaches the iminium intermediate for reaction. Molecular dynamics (MD) simulations were performed to investigate the origin of reaction stereoselectivity (see the Supporting Information for details). Our previous computational analysis indicates that the iminium and deprotonated nitromethane intermediates are formed in one step and thus they are extremely transient before forming a stereogenic center at C3.13 Hence, the reaction stereoselectivity is most likely dictated by the hemiaminal tetrahedral intermediate which forms prior to the iminium/deprotonated nitromethane pair. C1 of the hemiaminal tetrahedral intermediate can be either R or S, which exerts a strong effect on how C3 is being exposed for nucleophilic reaction (see Schemes S1and S2 in the Supporting Information). Interestingly, a representative snapshot of the (1S) intermediate from the MD simulation of Sav‐7 overlays well with the crystal structure complex (Figure 3). According to the population analysis obtained from the MD simulations, this (1S) intermediate dictates the stereoselectivity of the reaction. Upon dehydration, this intermediate will be converted into the iminium intermediate which exposes the C3 Si face for nucleophilic addition, whereas the opposite face is shielded by the protein (Figure 4). Consequently, formation of the stereoisomer (S)‐10 a is favored. Similarly, for the iminium derived from the (1R) intermediate, the C3 Si face of the iminium intermediate is exposed for reaction. In the case where 8 is used, formation of the (1R) intermediate is favored and the product stereoisomer is reversed (see Figure S7). However, this intermediate is noticeably more flexible, and analysis of the MD trajectory of this complex indicates that while the majority of the conformers (ca. 90 %) yield the (3R) adduct, there is a population of conformers that yield the opposite stereoisomer (see geometrical analysis and animation movies deposited in the Supporting Information).
Figure 3

Overlay of the 1.1 Å crystal structure of Sav‐7 (green) and the hemiaminal tetrahedral intermediates obtained from the MD simulations (yellow). Blue dashed lines denote proposed hydrogen‐bonding interactions.

Figure 4

Top: Tetrahedral intermediates (1R) and (1S) intermediate derived from QM/MM studies. Bottom: Schematic representation of the orientation of the iminium intermediate. The lower‐case A denotes residues within one subunit and lower‐case D denotes residues from the other subunit. Red refers to hypothetical hydrogen‐bonding interactions.

Overlay of the 1.1 Å crystal structure of Sav‐7 (green) and the hemiaminal tetrahedral intermediates obtained from the MD simulations (yellow). Blue dashed lines denote proposed hydrogen‐bonding interactions. Top: Tetrahedral intermediates (1R) and (1S) intermediate derived from QM/MM studies. Bottom: Schematic representation of the orientation of the iminium intermediate. The lower‐case A denotes residues within one subunit and lower‐case D denotes residues from the other subunit. Red refers to hypothetical hydrogen‐bonding interactions. Attempts to further enhance the reaction yield were made by prolonging the reaction time or raising the pH, but no improvement was found. Instead, there was a substantial amount of precipitation observed after 6–42 hours, and it can be caused either by imine formation between free amines of the protein and the aldehyde moieties or by aggregation resulting from surface binding of the hydrophobic reactants. To suppress the precipitation, different organic solvents were included as additives (Table 1). They can be separated into three categories: nonpolar (C6D6, CDCl3), polar aprotic (EtOAc, THF, DMSO, MeCN), and polar protic (MeOH) solvents.10i, 14 In all cases precipitate formation was suppressed but the reaction yield was improved only when either THF, EtOAc, or MeOH were included. However, reaction yields fluctuated severely when THF or EtOAc was used, and cinnamic acid was observed as a side product. Also, in THF up to 50 % of 1,2‐addition product was observed. The presence of MeOH enhances the reaction yield up to an average value of 80 % within 18 hours per mol % catalyst used. This data transforms into a rate enhancement (k cat/k uncat) of 8 and a ΔΔG ≠=5.12 kJ mol−1 with 10 % additional side products observed in the uncatalyzed background reaction. Such efficiency has not been seen in previously reported aqueous organocatalytic system.12c, 15 Furthermore, while the previously reported Sav‐based π‐stacking organocatalytic system operates best at low pH,1a in the Sav‐7 system such conditions were found to be detrimental for catalysis (ca. 5 % at pH 5.0 and no product observed at pH 3.0). Since MeOH proved to be the most productive cosolvent, the ratio of this solvent to buffer was screened for optimal reaction yield and enantioselectivity. Increasing the amount of MeOH steadily enhances both the yield and enantioselectivity of the model reaction (see Figure S8). A ratio of 1:1 of buffer/MeOH at pH 7.0 proved to be the optimal reaction conditions. In the control experiment where the Sav protein scaffold is omitted, no enantioselectivity was observed. Together, these data indicate that the stereoselectivity originates from the binding between Sav and 7, which remains intact even in the presence of a significant amount of MeOH. The applicability of the Sav‐7 system was explored by testing cinnamaldehyde derivatives and the respective ketones as alternative substrates (Table 2). Almost all of the employed aldehydes are tolerated by Sav‐7, giving acceptable to good yields (>35 %) and enantioselectivities (entries 1–7). The low yield of 4′‐nitrocinnamaldehyde (entry 5) is most likely caused by its low solubility in the buffer/MeOH mixture. In contrast, all of the ketone counterparts give poor yields, and only the ones shown in Table 2 afford a detectable yield.
Table 2

Exploration of substrate scope in the reaction of nitromethane with α,β‐unsaturated carbonyl compounds and Sav‐7.[a]

EntryR1, R2 Yield [%][b] e.r.[c]
1Ph, H; 9 a 809:91
24′‐MeC6H4, H; 9 b 3713:87
34′‐OMeC6H4, H; 9 c 3914:86
44′‐ClC6H4, H; 9 d 7911:89
54′‐NO2C6H4, H; 9 e 1024:76
6[d] 3′‐Py, H; 9 f 62n.d.
74′‐XC6H4, CH3;(X=Cl; 12 d, NO2; 12 e, CF3; 12 g)<2–5n.d.

[a] Reactions carried out for 18 h on a 3.3 μmol scale, using nitromethane (16.5 μmol), catalyst (1.0 mol %, additionally 0.2 mol % Sav, 1.2 mol % active sites) in 500 μL of mixed solvent, KPi/MeOH=1:1, KPi=10 mm, pH 7.0, and 25 °C. [b] Conversion determined by 1H NMR spectroscopy. [c] Determined by chiral‐phase LC of reduced products 11 a–11 f (see the Supporting Information). [d] The corresponding product was found to be degraded during purification, and thus the e.r. value was not determined. n.d.=not determined.

Exploration of substrate scope in the reaction of nitromethane with α,β‐unsaturated carbonyl compounds and Sav‐7.[a] [a] Reactions carried out for 18 h on a 3.3 μmol scale, using nitromethane (16.5 μmol), catalyst (1.0 mol %, additionally 0.2 mol % Sav, 1.2 mol % active sites) in 500 μL of mixed solvent, KPi/MeOH=1:1, KPi=10 mm, pH 7.0, and 25 °C. [b] Conversion determined by 1H NMR spectroscopy. [c] Determined by chiral‐phase LC of reduced products 11 a–11 f (see the Supporting Information). [d] The corresponding product was found to be degraded during purification, and thus the e.r. value was not determined. n.d.=not determined. In conclusion, a hybrid organocatalytic system based on the streptavidin‐biotin technology was developed in this work. This system facilitates secondary amine catalyzed reactions. Surprisingly, by simply exploiting the scaffold of the wild‐type streptavidin, a sparsely substituted cyclic secondary amine can be used to catalyze reactions with high enantioselectivity. This approach bypasses the need of striking a balance between reactivity and stereoselectivity as frequently seen in traditional organocatalyst design.8 Molecular simulations and protein crystallography have been particularly insightful, as they reveal how the protein dictates the orientation of the substrate and reaction stereoselectivity. This work lays the basis for protein engineering in which a designated scaffold can be modified for optimal organocatalysis.10d,10f,10g,10i–10k, 16 Furthermore, since this work enables organocatalysis in an isolated environment of a supramolecular complex, its compatibility with other species including reagents, other catalysts, and intermediates are greatly enhanced.1a,1c Hence, this protein‐based organocatalytic system will facilitate the development of tandem reaction sequences and hybrid catalysts as tools in chemical biology.17

Conflict of interest

The authors declare no conflict of interest. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Supplementary Click here for additional data file. Supplementary Click here for additional data file. Supplementary Click here for additional data file. Supplementary Click here for additional data file. Supplementary Click here for additional data file.
  40 in total

1.  Artificial metalloenzymes based on the biotin-avidin technology: enantioselective catalysis and beyond.

Authors:  Thomas R Ward
Journal:  Acc Chem Res       Date:  2010-10-15       Impact factor: 22.384

2.  Sequential and modular synthesis of chiral 1,3-diols with two stereogenic centers: access to all four stereoisomers by combination of organo- and biocatalysis.

Authors:  Katrin Baer; Marina Krausser; Edyta Burda; Werner Hummel; Albrecht Berkessel; Harald Gröger
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

3.  The design of a spiro-pyrrolidine organocatalyst and its application to catalytic asymmetric Michael addition for the construction of all-carbon quaternary centers.

Authors:  Jin-Miao Tian; Yong-Hai Yuan; Yong-Qiang Tu; Fu-Min Zhang; Xiao-Bo Zhang; Shi-Heng Zhang; Shao-Hua Wang; Xiao-Ming Zhang
Journal:  Chem Commun (Camb)       Date:  2015-06-21       Impact factor: 6.222

4.  Artificial transfer hydrogenases based on the biotin-(strept)avidin technology: fine tuning the selectivity by saturation mutagenesis of the host protein.

Authors:  Christophe Letondor; Anca Pordea; Nicolas Humbert; Anita Ivanova; Sylwester Mazurek; Marjana Novic; Thomas R Ward
Journal:  J Am Chem Soc       Date:  2006-06-28       Impact factor: 15.419

5.  Diphenylprolinol silyl ether as catalyst of an asymmetric, catalytic, and direct Michael reaction of nitroalkanes with alpha,beta-unsaturated aldehydes.

Authors:  Hiroaki Gotoh; Hayato Ishikawa; Yujiro Hayashi
Journal:  Org Lett       Date:  2007-11-13       Impact factor: 6.005

6.  Artificial Metalloenzymes Based on the Biotin-Streptavidin Technology: Challenges and Opportunities.

Authors:  Tillmann Heinisch; Thomas R Ward
Journal:  Acc Chem Res       Date:  2016-08-16       Impact factor: 22.384

7.  Diphenylprolinol silyl ether catalyzed asymmetric Michael reaction of nitroalkanes and β,β-disubstituted α,β-unsaturated aldehydes for the construction of all-carbon quaternary stereogenic centers.

Authors:  Yujiro Hayashi; Yuya Kawamoto; Masaki Honda; Daichi Okamura; Shigenobu Umemiya; Yuka Noguchi; Takasuke Mukaiyama; Itaru Sato
Journal:  Chemistry       Date:  2014-08-27       Impact factor: 5.236

8.  Artificial metalloenzymes for enantioselective catalysis based on biotin-avidin.

Authors:  Jérôme Collot; Julieta Gradinaru; Nicolas Humbert; Myriem Skander; Andrea Zocchi; Thomas R Ward
Journal:  J Am Chem Soc       Date:  2003-07-30       Impact factor: 15.419

9.  New organocatalyst scaffolds with high activity in promoting hydrazone and oxime formation at neutral pH.

Authors:  Dennis Larsen; Michael Pittelkow; Saswata Karmakar; Eric T Kool
Journal:  Org Lett       Date:  2014-12-29       Impact factor: 6.005

10.  On the Dielectric "Constant" of Proteins: Smooth Dielectric Function for Macromolecular Modeling and Its Implementation in DelPhi.

Authors:  Lin Li; Chuan Li; Zhe Zhang; Emil Alexov
Journal:  J Chem Theory Comput       Date:  2013-03-13       Impact factor: 6.006

View more
  10 in total

Review 1.  Selection, Addiction and Catalysis: Emerging Trends for the Incorporation of Noncanonical Amino Acids into Peptides and Proteins in Vivo.

Authors:  Clemens Mayer
Journal:  Chembiochem       Date:  2019-03-13       Impact factor: 3.164

2.  Reactivity and Selectivity of Iminium Organocatalysis Improved by a Protein Host.

Authors:  Alexander R Nödling; Katarzyna Świderek; Raquel Castillo; Jonathan W Hall; Antonio Angelastro; Louis C Morrill; Yi Jin; Yu-Hsuan Tsai; Vicent Moliner; Louis Y P Luk
Journal:  Angew Chem Int Ed Engl       Date:  2018-08-23       Impact factor: 15.336

3.  Directed Evolution of a Designer Enzyme Featuring an Unnatural Catalytic Amino Acid.

Authors:  Clemens Mayer; Christopher Dulson; Eswar Reddem; Andy-Mark W H Thunnissen; Gerard Roelfes
Journal:  Angew Chem Int Ed Engl       Date:  2019-01-14       Impact factor: 15.336

4.  The role of streptavidin and its variants in catalysis by biotinylated secondary amines.

Authors:  Alexander R Nödling; Nicolò Santi; Raquel Castillo; Magdalena Lipka-Lloyd; Yi Jin; Louis C Morrill; Katarzyna Świderek; Vicent Moliner; Louis Y P Luk
Journal:  Org Biomol Chem       Date:  2021-12-08       Impact factor: 3.876

Review 5.  Derivatives of Natural Organocatalytic Cofactors and Artificial Organocatalytic Cofactors as Catalysts in Enzymes.

Authors:  Horst Lechner; Gustav Oberdorfer
Journal:  Chembiochem       Date:  2022-04-01       Impact factor: 3.461

Review 6.  Unlocking New Reactivities in Enzymes by Iminium Catalysis.

Authors:  Guangcai Xu; Gerrit J Poelarends
Journal:  Angew Chem Int Ed Engl       Date:  2022-06-15       Impact factor: 16.823

7.  An Artificial Cofactor Catalyzing the Baylis-Hillman Reaction with Designed Streptavidin as Protein Host*.

Authors:  Horst Lechner; Vincent R Emann; M Breuning; Birte Höcker
Journal:  Chembiochem       Date:  2021-02-16       Impact factor: 3.164

8.  Streptavidin-Hosted Organocatalytic Aldol Addition.

Authors:  Nicolò Santi; Louis C Morrill; Louis Y P Luk
Journal:  Molecules       Date:  2020-05-25       Impact factor: 4.411

9.  Breaking Symmetry: Engineering Single-Chain Dimeric Streptavidin as Host for Artificial Metalloenzymes.

Authors:  Shuke Wu; Yi Zhou; Johannes G Rebelein; Miriam Kuhn; Hendrik Mallin; Jingming Zhao; Nico V Igareta; Thomas R Ward
Journal:  J Am Chem Soc       Date:  2019-09-25       Impact factor: 15.419

Review 10.  Enabling protein-hosted organocatalytic transformations.

Authors:  Alexander R Nödling; Nicolò Santi; Thomas L Williams; Yu-Hsuan Tsai; Louis Y P Luk
Journal:  RSC Adv       Date:  2020-04-23       Impact factor: 4.036

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.